Today, PIPC Chairman Tony Coelho was quoted in a piece by Inside Health Policy regarding Medicare Part B's drug payment policy. The Congressional commission, Medicare Payment Advisory Commission (MedPC), recently discussed support, from a small number of commissioners, for allowing CMS to return to the controversial “least costly alternative” model it used from 2005 to 2010 that MedPAC discussed at its September meeting. “As the Commission moves forward in their deliberations to improve outcomes and reduce costs in the Medicare program, PIPC hopes that MedPAC will pursue policies that activate patients and lead to long-term health improvements, rather than focusing on those that could threaten to jeopardize the nature of the doctor-patient relationship,” said Chairman Coelho.
PIPC has also publicly responded to MedPAC's discussion in September. That letter can be found here and the latest article from Inside Health Policy can be found here and below.